Serine Protease Inhibitor Kunitz-Type 2 Is Downregulated in Myelodysplastic Syndromes and Modulates Cell

Serine Protease Inhibitor Kunitz-Type 2 Is Downregulated in Myelodysplastic Syndromes and Modulates Cell–Cell Adhesion

Published:2014-05-15 Issue:10 Volume:23 Page:1109-1120
ISSN:1547-3287
Container-title:Stem Cells and Development
language:en
Short-container-title:Stem Cells and Development

Author:

Roversi Fernanda Marconi¹,Lopes Matheus Rodrigues¹,Machado-Neto João Agostinho¹,Longhini Ana Leda F.¹,Duarte Adriana da Silva Santos¹,Baratti Mariana Ozello¹,Palodetto Bruna¹,Corrocher Flávia Adolfo¹,Pericole Fernando Vieira¹,Campos Paula de Melo¹,Favaro Patricia¹²,Traina Fabiola¹²³,Saad Sara Teresinha Olalla¹

Affiliation:

1. Instituto Nacional de Ciência e Tecnologia do Sangue, Hematology and Hemotherapy Center, University of Campinas/Hemocentro—Unicamp, Campinas, Brazil.

2. Department of Biological Sciences, Federal University of São Paulo, Diadema, Brazil.

3. Department of Internal Medicine, University of São Paulo at Ribeirão Preto Medical School, Ribeirão Preto, Brazil.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Developmental Biology,Hematology

Link

https://www.liebertpub.com/doi/pdf/10.1089/scd.2013.0441

Reference46 articles.

1. The molecular pathogenesis of myelodysplastic syndromes

2. Intrinsic Growth Deficiencies of Mesenchymal Stromal Cells in Myelodysplastic Syndromes

3. Biologic Characteristics of Bone Marrow Mesenchymal Stem Cells in Myelodysplastic Syndromes